FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke

Abstract The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aneta Blat, Jakub Dybas, Karolina Chrabaszcz, Katarzyna Bulat, Agnieszka Jasztal, Magdalena Kaczmarska, Roman Pulyk, Tadeusz Popiela, Agnieszka Slowik, Kamilla Malek, Mateusz G. Adamski, Katarzyna M. Marzec
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d1506645241a416ea34cc675877cca5f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d1506645241a416ea34cc675877cca5f
record_format dspace
spelling oai:doaj.org-article:d1506645241a416ea34cc675877cca5f2021-12-02T15:09:39ZFTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke10.1038/s41598-019-51932-02045-2322https://doaj.org/article/d1506645241a416ea34cc675877cca5f2019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-51932-0https://doaj.org/toc/2045-2322Abstract The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologies: fibrin–predominant clot of large vessel origin and red blood cells–rich clot of cardioembolic origin. The synergy effect of Fourier–transform infrared spectroscopy (FTIR), Raman spectroscopy (RS) and atomic force microscopy (AFM) techniques supported by chemometrics in comparison with reference histological staining was presented. The main advantage of such approach refers to free–label and non–destructive quantitative imaging of clinically valid, biochemical parameters in whole sample (FTIR–low resolution) and selected regions (RS–ultra–high resolution). We may include here analysis of lipid content, its distribution and total degree of unsaturation as well as analysis of protein content (mainly fibrin and hemoproteins). The AFM studies enhanced the vibrational data, showed clearly shape and thickness of clot features as well as visualized the fibrin framework. The extraordinary sensitivity of FTIR and RS imaging toward detection and discrimination of clinically valid parameters in clot confirms its applicability in assessment of thrombi origin.Aneta BlatJakub DybasKarolina ChrabaszczKatarzyna BulatAgnieszka JasztalMagdalena KaczmarskaRoman PulykTadeusz PopielaAgnieszka SlowikKamilla MalekMateusz G. AdamskiKatarzyna M. MarzecNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Aneta Blat
Jakub Dybas
Karolina Chrabaszcz
Katarzyna Bulat
Agnieszka Jasztal
Magdalena Kaczmarska
Roman Pulyk
Tadeusz Popiela
Agnieszka Slowik
Kamilla Malek
Mateusz G. Adamski
Katarzyna M. Marzec
FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
description Abstract The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologies: fibrin–predominant clot of large vessel origin and red blood cells–rich clot of cardioembolic origin. The synergy effect of Fourier–transform infrared spectroscopy (FTIR), Raman spectroscopy (RS) and atomic force microscopy (AFM) techniques supported by chemometrics in comparison with reference histological staining was presented. The main advantage of such approach refers to free–label and non–destructive quantitative imaging of clinically valid, biochemical parameters in whole sample (FTIR–low resolution) and selected regions (RS–ultra–high resolution). We may include here analysis of lipid content, its distribution and total degree of unsaturation as well as analysis of protein content (mainly fibrin and hemoproteins). The AFM studies enhanced the vibrational data, showed clearly shape and thickness of clot features as well as visualized the fibrin framework. The extraordinary sensitivity of FTIR and RS imaging toward detection and discrimination of clinically valid parameters in clot confirms its applicability in assessment of thrombi origin.
format article
author Aneta Blat
Jakub Dybas
Karolina Chrabaszcz
Katarzyna Bulat
Agnieszka Jasztal
Magdalena Kaczmarska
Roman Pulyk
Tadeusz Popiela
Agnieszka Slowik
Kamilla Malek
Mateusz G. Adamski
Katarzyna M. Marzec
author_facet Aneta Blat
Jakub Dybas
Karolina Chrabaszcz
Katarzyna Bulat
Agnieszka Jasztal
Magdalena Kaczmarska
Roman Pulyk
Tadeusz Popiela
Agnieszka Slowik
Kamilla Malek
Mateusz G. Adamski
Katarzyna M. Marzec
author_sort Aneta Blat
title FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_short FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_full FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_fullStr FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_full_unstemmed FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_sort ftir, raman and afm characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/d1506645241a416ea34cc675877cca5f
work_keys_str_mv AT anetablat ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT jakubdybas ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT karolinachrabaszcz ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT katarzynabulat ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT agnieszkajasztal ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT magdalenakaczmarska ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT romanpulyk ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT tadeuszpopiela ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT agnieszkaslowik ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT kamillamalek ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT mateuszgadamski ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT katarzynammarzec ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
_version_ 1718387840871563264